Scientific-Methodological Approach to the Epidemiological Analysis and Laboratory Diagnostics of the Diseases Caused by Marburg and Ebola Viruses
https://doi.org/10.21055/0370-1069-2012-3-38-44
Abstract
About the Authors
A. M. TitenkoRussian Federation
E. I. Andaev
Russian Federation
References
1. “Safety of work with microorganisms of the I–II groups of pathoge- nicity”. SR 1.3.1285-03. M.; 2003.
2. Borisevich I.V., Markin V.A., Firsova I.V., Evseev A.A., Khamitov R.A., Maksimov V.A. [Epidemiology, prophylaxis, clinical picture and treat- ment of Marburg, Ebola, Lassa and Bolivian hemorrhagic fevers]. Vopr. Virusol. 2006; 5:8–16.
3. Viral Hemorrhagic Fevers. Report of the WHO Committee of Experts. Geneva; 1986. 119 p.
4. Drozdov S.G., Sergiev V.P. [Protection of Non-Endemic Territories from Tropical Viral Hemorrhagic Fevers]. M.; 1984. 288 p.
5. International Health Regulations. Geneva; 2005. 73 p.
6. Onishchenko G.G., Titenko A.M. [Current trends in the development of sanitary-epidemiological protection of the territories from importation and dissemination of particularly dangerous viral infections]. Bull. Sibirsk. Otd. RAMS. 2004; 4(1):110–6.
7. Onishchenko G.G., Kutyrev V.V., editors. [Corpus of the Normative Documents Regulating Organization of Work of the Rospotrebnadzor Specialized Anti-Epidemic Teams]. Saratov; 2008. 216 p.
8. Onischenko G.G., Kouzkin B.P., Kutyrev V.V., Scherbakova S.A., Pakskina N.D., Toporkov A.V. [Current trends of perfection of laboratory di- agnostics of particularly dangerous infectious diseases]. Probl. Osobo Opasn. Infek. 2009; (99):5–10.
9. Onishchenko G.G., Kutyrev V.V., editors. [Laboratory Diagnostics of Particularly Dangerous Infectious Diseases. Practice Guidelines]. M.; 2009. 470 p.
10. Onischenko G.G., Pakskina N.D., Toporkov V.P., Toporkov A.V., Shiyanova A.E., Kutyrev V.V. [Methodological principles of implementation of International Health Regulations (2005) in the Territory of the Russian Federation]. Probl. Osobo Opasn. Infek. 2010; (105):5–12.
11. [Organization and carrying-out of essential measures in case of detection a suspect (a corps) with infectious disease resulting in emergency situation in the sphere of sanitary-epidemiological welfare of the population: MR 3.4.2552-09]. M.; 2009. 112 p.
12. [Organization, implementation and evaluation of anti-epidemic pre- paredness program in health care institutions, consisting in carrying-out the measures in case of importing particularly dangerous infectious disease, or contagious viral hemorrhagic fevers, or infectious diseases of unknown etiolo- gy that are of a serious hazard to the population of both the Russian Federation and world community: MR 3.4.1030-01]. M.; 2001. 64 p.
13. [Organization of the activities in the laboratories practicing with amplification of nucleic acids when working with the materials containing microorganisms that fall into I–II groups of pathogenicity: MR 11.3.2569-09]. M.; 2009. 42p.
14. [Method of registration, storage, transfer, and transportation of mi- croorganism that fall into I–II groups of pathogenicity: SR 1.2.036-95]. M.; 1996. 80 p.
15. [Sanitary Protection of the Russian Federation Territories: SR 3.4.2318-08]. M.; 36 p.
16. Titenko A.M. [Marburg hemorrhagic fever]. Zh. Mikrobiol. Epidemiol. Immunobiol. 1991; 5:67–71.
17. Titenko A.M., Novozhilov S.S., Andaev E.I., Borisova T.I., Kulikova E.V. [Reproduction of Ebola virus in cell cultures]. Vopr. Virusol. 1992; 2:110–3.
18. Titenko A.M. [Ebola hemorrhagic fever]. Zh. Mikrobiol. Epidemiol. Immunobiol. 1993; 3:99–105.
19. Titenko A.M., Andaev E.I., Kulikova E.V., Borisova T.I. [Marburg and Ebola viruses: biological properties and development of the methods of laboratory diagnostics]. Zh. Infek. Patol. 1998; 5(4):75–9.
20. Titenko A.M., Andaev E.I., Borisova T.I. [Dynamics of antigen expression of Marburg and Ebola viruses within infected Vero cells]. Vopr. Virusol. 2001; 46(6):43–5.
21. Titenko A.M., Andaev E.I., Borisova T.I. [Detection of specific anti- bodies to Ebola and Marburg viruses using cell-bond enzyme-linked immuno- assay]. Biotekhnologya. 2002; 2:5–8.
22. Titenko A.M. [Sanitary protection of territories from importation and spread of viral infections. Communication 1. Present-day approaches]. Probl. Osobo Opasn. Infek. 2002; (84):144–50.
23. Titenko A.M., Botvinkin A.D., Andaev E.I. [Sanitary and epidemio- logic protection of territories from import and dissemination of viral infec- tions. Communication 2. Criteria for the analysis of nosologic forms]. Probl. Osobo Opasn. Infek. 2003; (85):41–9.
24. Titenko A.M. [Sanitary and Epidemiologic Protection of Territories from Import and Dissemination of Viral Infections. Communication 3. Differentiation of Infections According to Their Importance]. Probl. Osobo Opasn. Infek. 2004; (86):48–53.
25. Titenko A.M. [Factors contributing to the emergence and discover- ing of new viral infections]. Epidemiol. Infek. Bol. 2004; 1:51–5.
26. Cherkassky B.L. [Particularly Dangerous infectious Diseases]. M.; 1996. 160 p. 27. Cherkassky B.L. [Guidelines on General Epidemiology]. M.; 2001. 560 p.
27. Allela L., Boury O., Pouillot R., Delicat A., Yaba P., Kumulungui B. et al. Ebola virus antibody prevalence in dogs and human risk. Emerg. Infect. Dis. 2005; 11(3):385–90.
28. Bausch D.G., Borchert M., Grein T., Roth C., Swanepoel R. Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo. Emerg. Infect. Dis. 2003; 9(12):531–7.
29. Fieldman H. Emerging and reemerging of filoviruses. Arch. Virol. 1996; 11:77–100.
30. Gonzalez J.P., Nacoune E., Slenczka W., Vidal P, Morvan J.M. Ebola and Marburg virus antibody prevalence in selected population of the Central African Republic. Microbes Infect. 2000; 2(1):39–44.
31. Heffernan R.T., Pambo B., Hatchett R.J., Leman P.A., Swanepoel R., Ryder R.W. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooue-Ivindo region, Northeastern Gabon, 1997. J. Infect. Dis. 2005; 191(6):964–8.
32. Laboratory biosafety manual. World Health Organization: Geneva; 2003. 99 p.
33. Leroy E.M., Telfer P., Kumulungui B., Yaba P., Rouquet P., Roques P. et al. A serological survey of Ebola virus infection in central African nonhuman primates. J. Infect. Dis. 2004; 190(11):1895–9.
34. Martini G.A., Sitgert R., editors. Marburg virus disease. New York: Springer-Verlag; 1971. 231 р.
35. Swanepoel R., Smit S.B., Rollin P.E., Formenty P., Leman P.A. Studies of reservoir hosts for Marburg virus. Emerg. Infect. Dis. 2007; 13(12):1847–51.
36. Titenko А.М. Probable Role of Especially Dangerous Viral Infections in Occurrence of Extreme Situations. Scientific journal: Ulaanbaatar, 2003; 11:200–7.
37. WHO experts consultation on Ebola Reston patogenicity in humans. Geneva: Switzerland; 2009. P. 7–22.
38. Wkly. Epidemiol. Rec. World Health Organization. Geneva: Switzerland. 1975–2010.
Review
For citations:
Titenko A.M., Andaev E.I. Scientific-Methodological Approach to the Epidemiological Analysis and Laboratory Diagnostics of the Diseases Caused by Marburg and Ebola Viruses. Problems of Particularly Dangerous Infections. 2012;(3(113)):38-44. (In Russ.) https://doi.org/10.21055/0370-1069-2012-3-38-44